European heart journal, 2022-10, Vol.43 (38), p.3618-3731
- Humbert, Marc
- Kovacs, Gabor
- Hoeper, Marius M
- Badagliacca, Roberto
- Berger, Rolf M F
- Brida, Margarita
- Carlsen, Jørn
- Coats, Andrew J S
- Escribano-Subias, Pilar
- Ferrari, Pisana
- Ferreira, Diogenes S
- Ghofrani, Hossein Ardeschir
- Giannakoulas, George
- Kiely, David G
- Mayer, Eckhard
- Meszaros, Gergely
- Nagavci, Blin
- Olsson, Karen M
- Pepke-Zaba, Joanna
- Quint, Jennifer K
- Rådegran, Göran
- Simonneau, Gerald
- Sitbon, Olivier
- Tonia, Thomy
- Toshner, Mark
- Vachiery, Jean Luc
- Vonk Noordegraaf, Anton
- Delcroix, Marion
- Rosenkranz, Stephan
2022
Details
- Autor(en) / Beteiligte
- Humbert, Marc
- Kovacs, Gabor
- Hoeper, Marius M
- Badagliacca, Roberto
- Berger, Rolf M F
- Brida, Margarita
- Carlsen, Jørn
- Coats, Andrew J S
- Escribano-Subias, Pilar
- Ferrari, Pisana
- Ferreira, Diogenes S
- Ghofrani, Hossein Ardeschir
- Giannakoulas, George
- Kiely, David G
- Mayer, Eckhard
- Meszaros, Gergely
- Nagavci, Blin
- Olsson, Karen M
- Pepke-Zaba, Joanna
- Quint, Jennifer K
- Rådegran, Göran
- Simonneau, Gerald
- Sitbon, Olivier
- Tonia, Thomy
- Toshner, Mark
- Vachiery, Jean Luc
- Vonk Noordegraaf, Anton
- Delcroix, Marion
- Rosenkranz, Stephan
- Titel
- 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- Ist Teil von
- European heart journal, 2022-10, Vol.43 (38), p.3618-3731
- Ort / Verlag
- England
- Erscheinungsjahr
- 2022
- Link zum Volltext
- Quelle
- Oxford Journals 2020 Medicine
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0195-668X, 1522-9645eISSN: 1522-9645DOI: 10.1093/eurheartj/ehac237Titel-ID: cdi_swepub_primary_oai_lup_lub_lu_se_df9f0e5a_4692_4133_8f58_581cc5ab4490
- Format
- –
- Schlagworte
- abdominal radiography, altitude, ambrisentan, amlodipine, angioplasty, anticoagulant therapy, antiretrovirus agent, aortic stenosis, aortopulmonary shunt, arterial gas, assisted circulation, Balloon pulmonary angioplasty, beraprost, beta adrenergic receptor blocking agent, biochemical analysis, birth control, blood analysis, BMPR2 gene, bosentan, bosutinib, Cardiac and Cardiovascular Systems, cardiopulmonary exercise test, cardiovascular magnetic resonance, chronic kidney failure, chronic obstructive lung disease, Chronic thrombo-embolic pulmonary hypertension, chronic thromboembolic pulmonary hypertension, clinical decision making, Clinical Medicine, comorbidity, Congenital heart disease, Connective tissue disease, contraceptive behavior, coronavirus disease 2019, cyclophosphamide, dasatinib, denervation, digital subtraction angiography, diltiazem, dipeptidyl carboxypeptidase inhibitor, disease association, disease classification, disease control, disease course, disease severity, diuretic agent, drug approval, drug design, drug potentiation, drug safety, dynamic contrast enhanced computed tomography, early diagnosis, echocardiography, echography, electrocardiogram, endothelin receptor antagonist, Endothelin Receptor Antagonists, enkephalinase inhibitor, Europe, evidence based practice, exercise, felodipine, fluid challenge test, follow up, gene, genetic counseling, genetic screening, GRADE approach, guanylate cyclase activator, Guidelines, health care facility, health care management, health care personnel, heart arrhythmia, heart catheterization, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, heart left ventricle hypertrophy, heart lung transplantation, heart right ventricle failure, hematologic disease, hemoptysis, human, Human immunodeficiency virus infection, Humans, Hypertension, Pulmonary, Hypertension, Pulmonary - diagnosis, Hypertension, Pulmonary - therapy, hypoxia, iloprost, immunology, intensive care unit, interferon, interstitial lung disease, iron deficiency anemia, ivabradine, Kardiologi, Klinisk medicin, Left heart disease, liver transplantation, lung artery pressure, Lung disease, lung embolism, lung emphysema, lung function test, lung hemodynamics, Lung transplantation, macitentan, mediastinitis, Medical and Health Sciences, Medicin och hälsovetenskap, metabolic disorder, methamphetamine, microangiopathy, mitomycin, mitral valve disease, mortality risk, nifedipine, noninvasive ventilation, oxygen therapy, pathophysiology, patient compliance, patient empowerment, patient-reported outcome, phase 3 clinical trial (topic), Phosphodiesterase type 5 inhibitors, phosphodiesterase V inhibitor, physical activity, pneumococcal infection, Pneumococcus vaccine, ponatinib, portal hypertension, practice guideline, pregnancy, prognosis, prostacyclin, Prostacyclin analogues, prostacyclin derivative, Prostacyclin receptor agonists, psychosocial care, Pulmonary arterial hypertension, pulmonary artery denervation, pulmonary artery occlusion, Pulmonary endarterectomy, Pulmonary hypertension, pulmonary tumour thrombotic microangiopathy, rehabilitation care, Review, riociguat, risk assessment, risk factor, SARS-CoV-2 vaccine, schistosomiasis, selexipag, sildenafil, sodium glucose cotransporter 2 inhibitor, Soluble guanylate cyclase stimulators, surgical technique, systemic disease, systemic sclerosis, tadalafil, telemonitoring, terminal care, thorax radiography, thrombotic microangiopathy, travel, treprostinil, tricuspid valve regurgitation, vaccination, vasoreactivity test, ventilation-perfusion scan